NYSE:MCK - McKesson Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$146.50 -2.42 (-1.63 %)
(As of 05/21/2018 04:00 PM ET)
Previous Close$148.92
Today's Range$146.13 - $149.48
52-Week Range$134.25 - $178.86
Volume1.53 million shs
Average Volume1.72 million shs
Market Capitalization$30.73 billion
P/E Ratio12.62
Dividend Yield0.90%
Beta1.31

About McKesson (NYSE:MCK)

McKesson logoMcKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:MCK
CUSIP58155Q10
Phone415-983-8300

Debt

Debt-to-Equity Ratio0.63
Current Ratio1.07
Quick Ratio0.61

Price-To-Earnings

Trailing P/E Ratio12.62
Forward P/E Ratio11.55
P/E Growth1.37

Sales & Book Value

Annual Sales$198.53 billion
Price / Sales0.15
Cash Flow$17.6506 per share
Price / Cash8.30
Book Value$53.16 per share
Price / Book2.76

Profitability

EPS (Most Recent Fiscal Year)$11.61
Net Income$5.07 billion
Net Margins2.34%
Return on Equity22.98%
Return on Assets4.22%

Miscellaneous

Employees78,000
Outstanding Shares206,340,000

McKesson (NYSE:MCK) Frequently Asked Questions

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, April 26th. Stockholders of record on Friday, June 1st will be given a dividend of $0.34 per share on Monday, July 2nd. This represents a $1.36 annualized dividend and a dividend yield of 0.93%. The ex-dividend date is Thursday, May 31st. View McKesson's Dividend History.

How will McKesson's stock buyback program work?

McKesson announced that its Board of Directors has initiated a stock buyback plan on Thursday, October 27th 2016, which allows the company to buyback $4,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 114% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board of directors believes its stock is undervalued.

How were McKesson's earnings last quarter?

McKesson (NYSE:MCK) announced its quarterly earnings results on Thursday, October, 26th. The company reported $3.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.78 by $0.50. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.69 billion. McKesson had a return on equity of 22.98% and a net margin of 2.34%. McKesson's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.94 earnings per share. View McKesson's Earnings History.

When is McKesson's next earnings date?

McKesson is scheduled to release their next quarterly earnings announcement on Thursday, May, 24th 2018. View Earnings Estimates for McKesson.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY19 earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $13.00 -13.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.37. McKesson also updated its FY18 guidance to $12.50 -12.80 EPS.

What price target have analysts set for MCK?

15 brokerages have issued 12 month price objectives for McKesson's stock. Their predictions range from $130.00 to $205.00. On average, they anticipate McKesson's stock price to reach $176.0667 in the next twelve months. View Analyst Ratings for McKesson.

Who are some of McKesson's key competitors?

Who are McKesson's key executives?

McKesson's management team includes the folowing people:
  • Mr. John H. Hammergren, Chairman, CEO & Pres (Age 59)
  • Mr. Jorge L. Figueredo, Exec. VP of HR (Age 57)
  • Mr. Paul C. Julian, Exec. VP (Age 63)
  • Britt J. Vitalone, CFO & Exec. VP
  • Ms. Kathleen D. McElligott, Chief Technology Officer, Chief Information Officer and Exec. VP (Age 62)

Has McKesson been receiving favorable news coverage?

News stories about MCK stock have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. McKesson earned a news sentiment score of 0.12 on Accern's scale. They also assigned news articles about the company an impact score of 48.25 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are McKesson's major shareholders?

McKesson's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.60%), Massachusetts Financial Services Co. MA (3.37%), Boston Partners (1.96%), Pzena Investment Management LLC (1.28%), Northern Trust Corp (1.20%) and Kiltearn Partners LLP (0.93%). Company insiders that own McKesson stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Patrick Blake, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson.

Which major investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Sentry Investments Corp., BlackRock Inc., Taylor Asset Management Inc., Legal & General Group Plc, OMERS ADMINISTRATION Corp, Swiss National Bank, River & Mercantile Asset Management LLP and Prudential Financial Inc.. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs and Marie L/Ca Knowles. View Insider Buying and Selling for McKesson.

Which major investors are buying McKesson stock?

MCK stock was acquired by a variety of institutional investors in the last quarter, including Boston Partners, Swedbank, Natixis, Robeco Institutional Asset Management B.V., Wells Fargo & Company MN, Amundi Pioneer Asset Management Inc., Old Mutual Global Investors UK Ltd. and Kiltearn Partners LLP. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $146.50.

How big of a company is McKesson?

McKesson has a market capitalization of $30.73 billion and generates $198.53 billion in revenue each year. The company earns $5.07 billion in net income (profit) each year or $11.61 on an earnings per share basis. McKesson employs 78,000 workers across the globe.

How can I contact McKesson?

McKesson's mailing address is ONE POST ST, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]


MarketBeat Community Rating for McKesson (MCK)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  707 (Vote Outperform)
Underperform Votes:  352 (Vote Underperform)
Total Votes:  1,059
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

McKesson (NYSE:MCK) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
15 Wall Street analysts have issued ratings and price targets for McKesson in the last 12 months. Their average twelve-month price target is $176.0667, suggesting that the stock has a possible upside of 20.18%. The high price target for MCK is $205.00 and the low price target for MCK is $130.00. There are currently 1 sell rating, 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyHold
Consensus Rating Score: 2.472.472.532.47
Ratings Breakdown: 1 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $176.0667$176.0667$177.7333$172.7333
Price Target Upside: 20.18% upside22.95% upside6.89% upside23.06% upside

McKesson (NYSE:MCK) Consensus Price Target History

Price Target History for McKesson (NYSE:MCK)

McKesson (NYSE:MCK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/11/2018Bank of AmericaLower Price TargetBuy ➝ Buy$179.00 ➝ $172.00LowView Rating Details
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$165.00MediumView Rating Details
2/2/2018Credit Suisse GroupReiterated RatingSell$130.00HighView Rating Details
2/2/2018MizuhoLower Price TargetNeutral ➝ Neutral$186.00 ➝ $179.00HighView Rating Details
1/24/2018Jefferies GroupUpgradeHold ➝ Buy$205.00HighView Rating Details
1/23/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$173.00 ➝ $180.00MediumView Rating Details
1/17/2018Robert W. BairdReiterated RatingBuy$200.00LowView Rating Details
1/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$179.00LowView Rating Details
12/4/2017Deutsche BankInitiated CoverageBuy$175.00HighView Rating Details
10/27/2017Royal Bank of CanadaReiterated RatingHold$170.00N/AView Rating Details
10/10/2017CowenUpgradeMarket Perform ➝ Outperform$176.00 ➝ $189.00N/AView Rating Details
9/14/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$184.00 ➝ $172.00HighView Rating Details
6/29/2017Leerink SwannBoost Price TargetMarket Perform$170.00MediumView Rating Details
6/26/2017UBSReiterated RatingNeutral$156.00 ➝ $166.00N/AView Rating Details
5/23/2017JPMorgan ChaseUpgradeNeutral ➝ Overweight$189.00MediumView Rating Details
3/6/2017CitigroupBoost Price TargetBuy$169.00 ➝ $175.00N/AView Rating Details
1/18/2017Avondale PartnersUpgradeMarket Perform ➝ Outperform$157.00 ➝ $193.00N/AView Rating Details
11/11/2016Standpoint ResearchDowngradeBuy ➝ HoldN/AView Rating Details
9/19/2016ArgusReiterated RatingHoldN/AView Rating Details
9/16/2016Goldman SachsDowngradeBuy ➝ Neutral$210.00 ➝ $189.00N/AView Rating Details
6/29/2016FBR & CoReiterated RatingBuy$210.00N/AView Rating Details
6/1/2016Raymond JamesDowngradeStrong-Buy ➝ OutperformN/AView Rating Details
(Data available from 5/21/2016 forward)

Earnings

McKesson (NYSE:MCK) Earnings History and Estimates Chart

Earnings by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE:MCK) Earnings Estimates

2018 EPS Consensus Estimate: $12.24
2019 EPS Consensus Estimate: $12.89
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$2.85$2.88$2.87
Q2 20182$2.80$2.82$2.81
Q3 20182$2.90$2.91$2.91
Q4 20182$3.54$3.78$3.66
Q1 20191$2.82$2.82$2.82
Q2 20191$3.01$3.01$3.01
Q3 20191$3.24$3.24$3.24
Q4 20191$3.82$3.82$3.82

McKesson (NYSE MCK) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/24/2018$3.54N/AView Earnings Details
2/1/2018Q3 2018$2.92$3.41$51.9809 billion$53.6170 billionViewN/AView Earnings Details
10/26/2017Q2 2018$2.78$3.28$51.6944 billion$52.0610 billionViewN/AView Earnings Details
7/27/2017Q1 2018$2.81$2.46$51.2185 billion$51.0510 billionViewN/AView Earnings Details
5/18/2017Q4 17$3.04$3.39$49.4824 billion$48.7130 billionViewN/AView Earnings Details
1/25/2017Q317$2.95$3.03$50.71 billion$50.13 billionViewN/AView Earnings Details
10/27/2016Q217$3.05$2.94$24.16 billion$49.9570 billionViewListenView Earnings Details
7/27/2016Q117$3.33$3.50$50.32 billion$49.7330 billionViewListenView Earnings Details
5/4/2016Q416$3.14$2.44$46.83 billion$46.6780 billionViewN/AView Earnings Details
1/27/2016Q316$3.13$3.18$48.97 billion$47.8990 billionViewListenView Earnings Details
10/29/2015Q216$2.99$3.31$47.85 billion$48.60 billionViewListenView Earnings Details
7/29/2015Q116$2.89$3.14$46.02 billion$47.50 billionViewListenView Earnings Details
5/12/2015Q415$2.75$2.94$45.00 billion$44.9250 billionViewListenView Earnings Details
2/5/2015Q315$2.61$2.89$44.81 billion$47.0050 billionViewN/AView Earnings Details
10/28/2014Q215$2.73$2.79$42.99 billion$44.76 billionViewN/AView Earnings Details
7/31/2014Q115$2.34$2.49$40.65 billion$44.06 billionViewN/AView Earnings Details
5/12/2014Q414$2.40$2.55$35.89 billion$38.14 billionViewN/AView Earnings Details
1/31/2014Q314$1.85$1.45$38.57 billion$34.30 billionViewN/AView Earnings Details
10/24/2013Q214$2.03$2.27$32.16 billion$33.00 billionViewListenView Earnings Details
7/25/2013Q1 2014$1.71$2.07$32.60 billion$32.20 billionViewListenView Earnings Details
5/7/2013Q4 2013$2.30$1.45$32.01 billion$30.62 billionViewListenView Earnings Details
1/31/2013Q3 2013$1.62$1.41$30.81 billion$31.1870 billionViewListenView Earnings Details
10/25/2012$1.78$1.92ViewN/AView Earnings Details
7/26/2012$1.48$1.55ViewN/AView Earnings Details
4/30/2012$2.04$2.09ViewN/AView Earnings Details
1/30/2012$1.38$1.40ViewN/AView Earnings Details
10/25/2011$1.38$1.63ViewN/AView Earnings Details
7/28/2011$1.10$1.27ViewN/AView Earnings Details
5/3/2011$1.60$1.66ViewN/AView Earnings Details
1/31/2011$1.12$1.12ViewN/AView Earnings Details
10/26/2010Q2 2011$1.09$1.03ViewN/AView Earnings Details
7/30/2010Q1 2011$1.07$1.10ViewN/AView Earnings Details
5/3/2010Q4 2010$1.29$1.27ViewN/AView Earnings Details
1/26/2010Q3 2010$1.19$1.19ViewN/AView Earnings Details
10/27/2009Q2 2010$1.01$1.07ViewN/AView Earnings Details
7/28/2009Q1 2010$0.86$1.06ViewN/AView Earnings Details
5/4/2009Q4 2009$1.15$1.23ViewN/AView Earnings Details
1/26/2009Q3 2009$0.86$1.05ViewN/AView Earnings Details
10/28/2008Q2 2009$1.02$1.17ViewN/AView Earnings Details
7/23/2008Q1 2009$0.80$0.83ViewN/AView Earnings Details
5/5/2008Q4 2008$1.00$1.05ViewN/AView Earnings Details
1/31/2008Q3 2008$0.80$0.79ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

McKesson (NYSE:MCK) Dividend Information

McKesson pays an annual dividend of $1.36 per share, with a dividend yield of 0.93%. MCK's next quarterly dividend payment will be made on Monday, July 2. The company has grown its dividend for the last 5 consecutive years and is increasing its dividend by an average of 7.10% each year. McKesson pays out 11.71% of its earnings out as a dividend.
Next Dividend:7/2/2018
Annual Dividend:$1.36
Dividend Yield:0.93%
Dividend Growth:7.10% (3 Year Average)
Payout Ratio(s):11.71% (Trailing 12 Months of Earnings)
10.73% (Based on This Year's Estimates)
10.16% (Based on Next Year's Estimates)
7.71% (Based on Cash Flow)
Track Record:5 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE:MCK) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/26/2018quarterly$0.340.88%5/31/20186/1/20187/2/2018
2/1/2018quarterly$0.340.97%2/28/20183/1/20184/2/2018
10/26/2017quarterly$0.341%11/30/201712/1/20171/2/2018
7/26/2017quarterly$0.340.84%8/30/20179/1/201710/2/2017
5/24/2017quarterly$0.280.69%6/1/20176/5/20177/3/2017
1/25/2017quarterly$0.280.81%2/27/20173/1/20174/3/2017
10/27/2016quarterly$0.280.9%11/29/201612/1/20161/2/2017
7/26/2016quarterly$0.280.57%8/30/20169/1/201610/3/2016
5/25/2016quarterly$0.280.62%6/2/20166/6/20167/1/2016
1/27/2016quarterly$0.280.7%2/26/20163/1/20164/1/2016
10/30/2015quarterly$0.280.62%11/27/201512/1/20151/4/2016
7/29/2015quarterly$0.280.52%8/28/20159/1/201510/1/2015
5/27/2015quarterly$0.240.4%6/4/20156/8/20157/1/2015
1/29/2015quarterly$0.240.44%2/26/20153/2/20154/1/2015
10/21/2014quarterly$0.240.49%11/26/201412/1/20141/2/2015
7/30/2014quarterly$0.240.49%8/28/20149/2/201410/1/2014
5/28/2014quarterly$0.240.51%6/5/20146/9/20147/1/2014
1/29/2014quarterly$0.240.54%2/27/20143/3/20144/1/2014
10/25/2013quarterly$0.240.63%11/27/201312/2/20131/2/2014
7/25/2013quarterly$0.240.77%8/29/20139/3/201310/1/2013
5/22/2013quarterly$0.220.68%6/5/20136/7/20137/1/2013
1/30/2013quarterly$0.200.76%2/27/20133/1/20134/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

McKesson (NYSE MCK) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 88.37%
Insider Trading History for McKesson (NYSE:MCK)
Institutional Ownership by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE MCK) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2018Erin M. LampertSVPSell1,413$149.38$211,073.94View SEC Filing  
12/14/2017John H. HammergrenChairmanSell65,000$160.00$10,400,000.00View SEC Filing  
9/29/2017John H HammergrenCEOSell99,000$153.89$15,235,110.00165,000View SEC Filing  
9/28/2017John H HammergrenCEOSell100,000$153.51$15,351,000.00165,000View SEC Filing  
9/27/2017John H HammergrenCEOSell100,000$155.30$15,530,000.00165,000View SEC Filing  
9/26/2017John H HammergrenCEOSell100,000$154.81$15,481,000.00165,000View SEC Filing  
9/25/2017John H HammergrenCEOSell100,000$154.15$15,415,000.00165,000View SEC Filing  
9/22/2017John H. HammergrenChairmanSell225,000$151.67$34,125,750.00View SEC Filing  
9/22/2017John H. HammergrenCEOSell100,000$153.53$15,353,000.00View SEC Filing  
9/20/2017John H. HammergrenCEOSell125,000$150.18$18,772,500.00View SEC Filing  
9/7/2017Erin M. LampertSVPSell900$155.65$140,085.00View SEC Filing  
8/21/2017M Christine JacobsDirectorSell1,083$145.43$157,500.69View SEC Filing  
7/31/2017Marie L/Ca KnowlesDirectorSell1,083$162.55$176,041.65View SEC Filing  
6/1/2017John H HammergrenChairmanSell38,619$163.76$6,324,247.4419,309View SEC Filing  
5/31/2017Erin M LampertSVPSell809$160.66$129,973.9459View SEC Filing  
5/30/2017Erin M LampertSVPSell404$160.53$64,854.122,003View SEC Filing  
5/30/2017John H HammergrenChairmanSell19,316$162.31$3,135,179.9696,644View SEC Filing  
3/29/2017John H HammergrenChairmanSell100,500$150.44$15,119,220.0022,390View SEC Filing  
3/2/2017John H HammergrenChairmanSell100,500$150.49$15,124,245.0057,900View SEC Filing  
12/5/2016Wayne A. BuddDirectorSell723$145.77$105,391.71View SEC Filing  
11/30/2016Lori A SchechterEVPBuy692$144.52$100,007.84View SEC Filing  
11/2/2016Susan R SalkaDirectorBuy1,000$136.35$136,350.00View SEC Filing  
10/31/2016Erin M LampertSVPSell921$123.99$114,194.791,765View SEC Filing  
10/3/2016Erin M. LampertSVPSell1,739$165.94$288,569.66View SEC Filing  
9/12/2016John H HammergrenChairmanSell100,500$180.77$18,167,385.00100,500View SEC Filing  
9/12/2016Wayne A BuddDirectorSell2,309$179.70$414,927.30723View SEC Filing  
9/6/2016John H HammergrenChairmanSell100,500$184.22$18,514,110.00100,500View SEC Filing  
8/22/2016M Christine JacobsDirectorSell915$193.78$177,308.70View SEC Filing  
8/1/2016Marie L/Ca KnowlesDirectorSell915$192.73$176,347.95View SEC Filing  
7/14/2016James A BeerCFOSell5,500$199.00$1,094,500.0012,412View SEC Filing  
5/25/2016John H HammergrenCEOSell37,420$182.87$6,842,995.4018,711View SEC Filing  
5/25/2016Patrick BlakeEVPSell6,322$182.87$1,156,104.145,328View SEC Filing  
5/24/2016John H HammergrenCEOSell18,709$182.06$3,406,160.5418,711View SEC Filing  
5/24/2016Lori A SchechterEVPSell107$182.06$19,480.426,259View SEC Filing  
5/23/2016John H HammergrenCEOSell18,718$179.33$3,356,698.9494,000View SEC Filing  
5/23/2016Patrick BlakeEVPSell3,162$179.33$567,041.4620,167View SEC Filing  
5/10/2016John H HammergrenCEOSell101,833$170.71$17,383,911.43101,833View SEC Filing  
4/25/2016John H HammergrenCEOSell101,833$176.81$18,005,092.73101,833View SEC Filing  
4/4/2016John H HammergrenCEOSell45,300$159.00$7,202,700.0045,300View SEC Filing  
3/15/2016Nigel A ReesSVPSell6,000$157.59$945,540.0011,000View SEC Filing  
2/2/2016Susan R SalkaDirectorBuy1,000$156.21$156,210.00View SEC Filing  
2/1/2016Lori A. SchechterEVPSell2,476$159.73$395,491.48View SEC Filing  
1/4/2016John H. HammergrenCEOSell101,833$194.11$19,766,803.63View SEC Filing  
12/1/2015John H. HammergrenCEOSell101,833$190.06$19,354,379.98View SEC Filing  
11/24/2015John H. HammergrenCEOSell56,533$190.01$10,741,835.33View SEC Filing  
10/12/2015John H. HammergrenCEOSell101,835$190.51$19,400,585.85View SEC Filing  
8/13/2015Paul C JulianEVPSell55,666$214.54$11,942,583.64View SEC Filing  
7/15/2015Paul C JulianEVPSell27,833$234.04$6,514,035.32View SEC Filing  
7/14/2015Paul C JulianEVPSell27,833$232.86$6,481,192.38View SEC Filing  
6/17/2015Paul C JulianEVPSell55,668$234.06$13,029,652.08View SEC Filing  
5/28/2015John H HammergrenCEOSell60,000$238.53$14,311,800.00View SEC Filing  
5/28/2015Lori A SchechterEVPSell1,468$238.22$349,706.96View SEC Filing  
5/26/2015John H HammergrenCEOSell30,062$238.97$7,183,916.14View SEC Filing  
5/26/2015Paul C JulianEVPSell15,289$238.97$3,653,612.33View SEC Filing  
5/22/2015Jorge FigueredoEVPSell20,775$240.11$4,988,285.25View SEC Filing  
5/15/2015Jorge FigueredoEVPSell8,525$240.00$2,046,000.00View SEC Filing  
2/17/2015Randall N SprattEVPSell44,523$225.00$10,017,675.00View SEC Filing  
2/12/2015Randall N SprattEVPSell7,477$225.00$1,682,325.00View SEC Filing  
2/10/2015Alton F Irby IIIDirectorSell5,000$220.76$1,103,800.00View SEC Filing  
2/10/2015Nigel A ReesMajor ShareholderSell9,000$220.42$1,983,780.00View SEC Filing  
1/28/2015John H HammergrenCEOSell64,521$219.52$14,163,649.92View SEC Filing  
1/26/2015Brian Scott TylerEVPSell5,431$216.62$1,176,463.22View SEC Filing  
1/26/2015John H HammergrenCEOSell35,479$219.07$7,772,384.53View SEC Filing  
1/7/2015John H HammergrenCEOSell77,100$214.00$16,499,400.00View SEC Filing  
12/8/2014John H HammergrenCEOSell12,200$214.01$2,610,922.00View SEC Filing  
11/28/2014Patrick BlakeEVPSell19,000$210.00$3,990,000.00View SEC Filing  
11/24/2014John H HammergrenCEOSell100,000$209.25$20,925,000.00View SEC Filing  
11/12/2014Paul C JulianEVPSell74,666$202.51$15,120,611.66View SEC Filing  
10/31/2014Patrick BlakeEVPSell38,000$204.68$7,777,840.00View SEC Filing  
10/8/2014Paul C JulianEVPSell74,667$195.86$14,624,278.62View SEC Filing  
10/7/2014John H HammergrenCEOSell100,000$197.28$19,728,000.00View SEC Filing  
9/10/2014Paul C JulianEVPSell74,667$196.76$14,691,478.92View SEC Filing  
8/29/2014Jorge FigueredoEVPSell24,500$195.00$4,777,500.00View SEC Filing  
8/8/2014M Christine JacobsDirectorSell2,619$189.88$497,295.72View SEC Filing  
8/5/2014Marie L/Ca KnowlesDirectorSell785$192.10$150,798.50View SEC Filing  
6/2/2014Patrick BlakeEVPSell15,000$190.00$2,850,000.00View SEC Filing  
5/29/2014Paul C JulianEVPSell21,057$186.89$3,935,342.73View SEC Filing  
5/28/2014Alton F Irby IIIDirectorSell4,000$182.73$730,920.00View SEC Filing  
5/28/2014John H HammergrenCEOSell125,596$183.31$23,023,002.76View SEC Filing  
5/28/2014Jorge FigueredoEVPSell20,542$183.30$3,765,348.60View SEC Filing  
5/27/2014Brian Scott TylerEVPSell3,916$183.30$717,802.80View SEC Filing  
5/22/2014Brian Scott TylerEVPSell8,250$184.17$1,519,402.505View SEC Filing  
3/21/2014Jorge FigueredoEVPSell23,684$185.81$4,400,724.04View SEC Filing  
3/10/2014Patrick BlakeEVPSell38,750$180.36$6,988,950.001,827View SEC Filing  
2/4/2014Brian Scott TylerEVPSell6,250$169.68$1,060,500.005View SEC Filing  
1/22/2014Alton Irby IIIDirectorSell1,300$167.98$218,374.0025,599View SEC Filing  
11/1/2013Nigel A ReesCFOSell7,000$158.72$1,111,040.00View SEC Filing  
10/29/2013Brian Scott TylerEVPSell8,250$153.44$1,265,880.00View SEC Filing  
10/11/2013Brian Scott TylerEVPSell9,000$138.51$1,246,590.005View SEC Filing  
10/9/2013Paul JulianEVPSell84,000$134.04$11,259,360.0057View SEC Filing  
10/8/2013Brian Scott TylerEVPSell9,000$138.00$1,242,000.005View SEC Filing  
9/11/2013Paul C JulianEVPSell84,000$126.20$10,600,800.00View SEC Filing  
8/7/2013Paul JulianEVPSell84,000$123.29$10,356,360.0057View SEC Filing  
8/6/2013Marie L/Ca KnowlesDirectorSell1,223$123.54$151,089.42View SEC Filing  
7/30/2013Brian Scott TylerEVPSell6,250$123.94$774,625.00View SEC Filing  
6/19/2013Paul C JulianEVPSell84,750$114.89$9,736,927.50View SEC Filing  
6/14/2013David M LawrenceDirectorSell7,500$114.28$857,100.00View SEC Filing  
6/14/2013Jorge FigueredoEVPSell6,250$115.00$718,750.00View SEC Filing  
6/10/2013Jorge FigueredoEVPSell10,000$115.00$1,150,000.00View SEC Filing  
6/4/2013Jorge FigueredoEVPSell22,500$113.63$2,556,675.00View SEC Filing  
5/30/2013Laureen SeegerEVPSell57,750$114.89$6,634,897.50View SEC Filing  
5/29/2013John H HammergrenCEOSell230,484$115.21$26,554,061.64View SEC Filing  
5/29/2013Randall N SprattEVPSell32,226$115.21$3,712,757.46View SEC Filing  
5/28/2013Brian Scott TylerEVPSell6,023$116.33$700,655.59View SEC Filing  
5/28/2013Jeffrey C CampbellCFOSell73,102$116.33$8,503,955.66View SEC Filing  
5/24/2013Laureen SeegerEVPSell17,250$116.50$2,009,625.00View SEC Filing  
5/22/2013Laureen SeegerEVPSell17,250$118.13$2,037,742.50View SEC Filing  
5/20/2013Brian Scott TylerEVPSell5,000$117.81$589,050.00View SEC Filing  
5/15/2013Nigel A ReesVPSell8,000$116.00$928,000.00View SEC Filing  
5/10/2013Brian Scott TylerEVPSell6,250$115.59$722,437.50View SEC Filing  
5/10/2013John H HammergrenCEOSell75,000$115.30$8,647,500.00View SEC Filing  
1/18/2013Jorge FigueredoEVPSell2,500$103.22$258,050.00View SEC Filing  
1/17/2013Laureen SeegerEVPSell17,250$103.00$1,776,750.00View SEC Filing  
9/4/2012Paul C JulianEVPSell36,250$87.02$3,154,475.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

McKesson (NYSE MCK) News Headlines

Source:
DateHeadline
Investors have shrugged off Trump drug price plan, but it could be earlyInvestors have shrugged off Trump drug price plan, but it could be early
finance.yahoo.com - May 21 at 8:30 AM
Spend it like Buffett: McKessons stock is trading close to the 52-week lowSpend it like Buffett: McKesson's stock is trading close to the 52-week low
www.theglobeandmail.com - May 20 at 5:43 PM
Critical Review: McKesson (MCK) & Trxade Group (TRXD)Critical Review: McKesson (MCK) & Trxade Group (TRXD)
www.americanbankingnews.com - May 20 at 5:24 AM
Herbal Center (HLF) & McKesson (MCK) Head-To-Head SurveyHerbal Center (HLF) & McKesson (MCK) Head-To-Head Survey
www.americanbankingnews.com - May 17 at 3:23 PM
McKesson (MCK) to Release Earnings on ThursdayMcKesson (MCK) to Release Earnings on Thursday
www.americanbankingnews.com - May 17 at 1:16 AM
Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma DrugReal-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug
www.businesswire.com - May 16 at 5:40 PM
Will Core Distribution Unit Aid McKesson (MCK) Q4 Earnings?Will Core Distribution Unit Aid McKesson (MCK) Q4 Earnings?
www.zacks.com - May 16 at 8:46 AM
McKesson Board Cant Dodge Opioid Shipment `Red Flags SuitMcKesson Board Can't Dodge Opioid Shipment `Red Flags' Suit
finance.yahoo.com - May 16 at 8:46 AM
Rite Aid (RAD)/Albertsons More Likely to Depart McKesson (MCK), a Positive for AmerisourceBergen (ABC) - RBCRite Aid (RAD)/Albertsons More Likely to Depart McKesson (MCK), a Positive for AmerisourceBergen (ABC) - RBC
www.streetinsider.com - May 15 at 5:32 PM
$51.58 Billion in Sales Expected for McKesson (MCK) This Quarter$51.58 Billion in Sales Expected for McKesson (MCK) This Quarter
www.americanbankingnews.com - May 15 at 5:03 AM
McKesson (MCK) Expected to Announce Earnings of $3.54 Per ShareMcKesson (MCK) Expected to Announce Earnings of $3.54 Per Share
www.americanbankingnews.com - May 13 at 1:22 AM
Consolidated Research: 2018 Summary Expectations for STORE Capital, Microvision, International Game Technology ...Consolidated Research: 2018 Summary Expectations for STORE Capital, Microvision, International Game Technology ...
globenewswire.com - May 11 at 9:02 AM
McKesson (MCK) Set to Announce Quarterly Earnings on WednesdayMcKesson (MCK) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - May 9 at 1:16 AM
McKesson ideaShare: The Independents Power to PerformMcKesson ideaShare: The Independent's Power to Perform
www.businesswire.com - May 7 at 5:34 PM
McKesson To Acquire MSD For Medical Supply DistributionMcKesson To Acquire MSD For Medical Supply Distribution
seekingalpha.com - May 7 at 5:34 PM
Former McKesson VP David Nace MD Joins Leading Healthcare Data Platform Company Innovaccer as Chief Medical OfficerFormer McKesson VP David Nace MD Joins Leading Healthcare Data Platform Company Innovaccer as Chief Medical Officer
www.prnewswire.com - May 3 at 11:58 AM
Critical Comparison: McKesson (MCK) versus PetIQ (PETQ)Critical Comparison: McKesson (MCK) versus PetIQ (PETQ)
www.americanbankingnews.com - May 2 at 10:31 AM
Head to Head Contrast: Nu Skin Enterprises (NUS) vs. McKesson (MCK)Head to Head Contrast: Nu Skin Enterprises (NUS) vs. McKesson (MCK)
www.americanbankingnews.com - May 2 at 1:24 AM
McKesson (MCK) Receives Average Recommendation of "Hold" from AnalystsMcKesson (MCK) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 30 at 3:40 PM
Form 8-K MCKESSON CORP For: Apr 24Form 8-K MCKESSON CORP For: Apr 24
www.streetinsider.com - April 30 at 9:31 AM
McKesson Board of Directors Elects Brad Lerman as New Independent DirectorMcKesson Board of Directors Elects Brad Lerman as New Independent Director
finance.yahoo.com - April 30 at 9:31 AM
McKesson Corporation Fiscal 2018 Fourth Quarter Conference Call Scheduled for May 24, 2018McKesson Corporation Fiscal 2018 Fourth Quarter Conference Call Scheduled for May 24, 2018
finance.yahoo.com - April 30 at 9:31 AM
Rexall to shutter some stores as pharmacy market faces pressureRexall to shutter some stores as pharmacy market faces pressure
www.theglobeandmail.com - April 27 at 5:28 PM
McKesson Internal Review Clears Senior Management of Wrongdoing on OpioidsMcKesson Internal Review Clears Senior Management of Wrongdoing on Opioids
finance.yahoo.com - April 27 at 8:05 AM
 Analysts Expect McKesson (MCK) Will Announce Quarterly Sales of $51.58 Billion Analysts Expect McKesson (MCK) Will Announce Quarterly Sales of $51.58 Billion
www.americanbankingnews.com - April 27 at 3:00 AM
McKesson Announces Quarterly Dividend of $0.34 (MCK)McKesson Announces Quarterly Dividend of $0.34 (MCK)
www.americanbankingnews.com - April 26 at 6:10 PM
[$$] McKesson Launches Comprehensive Review of Operations[$$] McKesson Launches Comprehensive Review of Operations
finance.yahoo.com - April 26 at 5:28 PM
McKesson (MCK) Releases FY18 Earnings GuidanceMcKesson (MCK) Releases FY18 Earnings Guidance
www.americanbankingnews.com - April 25 at 5:50 PM
McKesson (MCK) Updates FY19 Earnings GuidanceMcKesson (MCK) Updates FY19 Earnings Guidance
www.americanbankingnews.com - April 25 at 5:50 PM
BRIEF-McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 OutlookBRIEF-McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook
www.reuters.com - April 25 at 5:29 PM
McKesson (MCK) to Acquire MSD for $800M; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 ...McKesson (MCK) to Acquire MSD for $800M; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 ...
www.streetinsider.com - April 25 at 5:29 PM
McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 OutlookMcKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 Outlook
finance.yahoo.com - April 25 at 5:29 PM
McKesson (MCK) Expected to Post Earnings of $3.54 Per ShareMcKesson (MCK) Expected to Post Earnings of $3.54 Per Share
www.americanbankingnews.com - April 25 at 1:24 PM
PolarityTE (COOL) Names Willie Bogan to BoardPolarityTE (COOL) Names Willie Bogan to Board
www.streetinsider.com - April 25 at 8:27 AM
BRIEF-Polarityte Announces Appointment Of MckessonS Willie Bogan To Board Of DirectorsBRIEF-Polarityte Announces Appointment Of Mckesson'S Willie Bogan To Board Of Directors
www.reuters.com - April 24 at 5:29 PM
McKessons Board Clears Itself of Fault on Opioid OversightMcKesson's Board Clears Itself of Fault on Opioid Oversight
www.bloomberg.com - April 24 at 8:04 AM
Glenviews Robbins pitches Long on Express Scripts (ESRX), McKesson (MCK), and CVS Health (CVS) at Sohn; Says ...Glenview's Robbins pitches Long on Express Scripts (ESRX), McKesson (MCK), and CVS Health (CVS) at Sohn; Says ...
www.streetinsider.com - April 23 at 5:25 PM
McKessons Board Clears Itself of Wrongdoing on Opioid OversightMcKesson's Board Clears Itself of Wrongdoing on Opioid Oversight
finance.yahoo.com - April 23 at 5:25 PM
PetIQ (PETQ) and McKesson (MCK) Financial ReviewPetIQ (PETQ) and McKesson (MCK) Financial Review
www.americanbankingnews.com - April 21 at 11:14 AM
McKesson (MCK) Upgraded at VetrMcKesson (MCK) Upgraded at Vetr
www.americanbankingnews.com - April 20 at 9:12 PM
McKesson (MCK) Given "Neutral" Rating at UBSMcKesson (MCK) Given "Neutral" Rating at UBS
www.americanbankingnews.com - April 20 at 5:52 PM
Earns New Patent for Proprietary Inventory Management TechnologyEarns New Patent for Proprietary Inventory Management Technology
www.businesswire.com - April 20 at 5:37 PM
McKesson (MCK) Lifted to "Buy" at Zacks Investment ResearchMcKesson (MCK) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 18 at 8:00 PM
Vetr Lowers McKesson (MCK) to BuyVetr Lowers McKesson (MCK) to Buy
www.americanbankingnews.com - April 18 at 12:16 PM
McKesson Is UndervaluedMcKesson Is Undervalued
seekingalpha.com - April 16 at 9:08 AM
McKesson (MCK) Lowered to Hold at BidaskClubMcKesson (MCK) Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 14 at 10:19 PM
Congress Sets Opioid Hearing Next Month for Drug DistributorsCongress Sets Opioid Hearing Next Month for Drug Distributors
finance.yahoo.com - April 13 at 5:34 PM
Want To Invest In McKesson Corporation (NYSE:MCK)? Here’s How It Performed LatelyWant To Invest In McKesson Corporation (NYSE:MCK)? Here’s How It Performed Lately
finance.yahoo.com - April 13 at 8:26 AM
Contrasting Nu Skin Enterprises (NUS) & McKesson (MCK)Contrasting Nu Skin Enterprises (NUS) & McKesson (MCK)
www.americanbankingnews.com - April 13 at 5:07 AM
McKesson (MCK) PT Lowered to $172 at BofA/Merrill LynchMcKesson (MCK) PT Lowered to $172 at BofA/Merrill Lynch
www.streetinsider.com - April 12 at 8:37 AM

SEC Filings

McKesson (NYSE:MCK) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

McKesson (NYSE:MCK) Income Statement, Balance Sheet and Cash Flow Statement

Chart

McKesson (NYSE MCK) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.